List of largest biotechnology and pharmaceutical companies

From Wikipedia, the free encyclopedia
  (Redirected from List of biotechnology companies)
Jump to navigation Jump to search

The following is a list of the independent biotechnology companies listed on a stock exchange (as indicated) with current market capitalization of at least USD 10 billion, in decreasing order.

The list does not include biotechnology companies that are currently owned by, or a part of, larger pharmaceutical groups.

Rankings[edit]

Rank[N 1] Company Largest Market Cap (USD billions) Market Cap in Q3 2018 (USD billions) Market Cap in 2017 (USD billions) Market Cap in 2016 (USD billions)[1][2] Market Cap in 2015 (USD billions)[3] Market Cap in 2014 (USD billions)[4] Market Cap in 2013 (USD billions)
1 Steady United States Johnson & Johnson[P]
NYSEJNJ
397.4 (Jan 2018) 370.6 Increase 375.4 314.1 284.2 277.8 258.3
2 Steady United States Pfizer[P]
NYSEPFE
310.5 (Jul 2000) 262.2 Increase 215.9 196.3 199.3 205.4 196.0
3 Steady Switzerland Roche[P]
OTCQXRHHBY
263.6 (Feb 2014) 201.4 Increase 216.7 192.1 234.7 258.5 240.3
4 Steady Switzerland Novartis[P]
NYSENVS
275.2 (Jul 2015) 200.8 Increase 196.7 170.5 206.1 229.8 195.0
5 Increase1 United States AbbVie[P]
NYSEABBV
196.2 (Jan 2018) 191.0 Increase 154.4 100.2 96.8 104.1 83.8
6 Decrease1 United States Merck & Co.[P]
NYSEMRK
196.2 (Mar 2017) 163.4 Increase 153.3 164.3 147.6 166.9 146.5
7 Steady United States Amgen[B]
NASDAQAMGN
143.0 (Jan 2018) 137.2 Increase 126.2 108.9 122.5 93.1 78.7
8 Increase1 United States Abbott Laboratories[P]
NYSEABT
129.9 (Oct 2018) 128.6 Increase 99.3 56.4 67.0 67.9 59.3
9 Decrease1 Denmark Novo Nordisk[P]
NYSENVO
159.6 (Aug 2015) 114.5 Increase 131.2 92.6 153.9 125.4 19.6
10 Steady United States Eli Lilly & Co[P]
NYSELLY
125.3 (Oct 2018) 116.5 Increase 93.0 80.9 93.4 76.6 57.0
11 Increase1 France Sanofi[P]
NYSESNY
151.3 (Sep 2014) 111.5 Increase 108.2 101.8 111.8 138.1 142.0
12 Increase3 United States Bristol-Myers Squibb[P]
NASDAQBMY
128.3 (Jul 2016) 101.5 Decrease 100.3 98.2 114.8 97.6 87.2
13 Increase1 United States Gilead Sciences[B]
NASDAQGILD
179.6 (Jun 2013) 100.7 Increase 93.6 96.6 145.8 109.0 78.4
14 Increase2 United Kingdom AstraZeneca[P]
NYSEAZN
102.9 (Oct 2006) 100.2 Increase 87.9 68.8 85.8 88.9 74.6
15 Decrease4 United Kingdom GlaxoSmithKline[P]
NYSEGSK
174.9 (May 2006) 99.6 Decrease 87.9 93.3 97.6 128.9 129.6
16 Increase2 United States Biogen[P]
NASDAQBIIB
111.7 (Mar 2015) 74.6 Increase 67.4 61.6 68.3 79.7 66.1
17 Steady United States Stryker Corporation[P]
NYSESYK
67.2 (June 2018) 66.4 Increase 58.0 45.1 34.7 35.7 28.4
18 Increase2 Republic of Ireland Allergan[P]
NYSEAGN
133.5 (Jul 2015) 65.9 Increase 54.4 72.7 123.3 68.5 29.3
19 Steady United States Celgene[B]
NASDAQCELG
115.3 (Oct 2017) 65.0 Increase 82.2 91.4 94.1 89.5 69.2
20 Decrease10 Germany Bayer[B]
FWBBAYN
129.0 (Mar 2015) 61.5 Decrease 101.9 85.3 103.2 113.2 117.4
21 Steady Republic of Ireland Shire Pharmaceuticals[P]
NASDAQSHPG
62.0 (Sep 2014) 55.2 Increase 47.0 50.1 41.0 42.4 28.1
22 Increase1 United States Illumina [B]
NASDAQILMN
54.0 (Sept 2018) 54.0 Increase 40.2 39.4 35.4 28.6 25.7
23 Decrease1 United States Vertex Pharmaceuticals[P]
NASDAQVRTX
49.1 (Sept 2018) 49.1 Increase 37.9 18.3 31.0 28.7 17.4
24 Steady United States Zoetis[P]
NASDAQZTS
45.3 (Sept 2018) 44.3 Increase 35.1 26.4 23.8 21.6 16.3
25 Steady United States Regeneron Pharmaceuticals Inc[P]
NASDAQREGN
61.4 (Aug 2015) 43.6 Increase 40.4 39.3 56.5 42.0 27.4
26 Increase1 Japan Astellas[P]
TYO: 4503
35.9 (Nov 2017) 34.5 Increase 29.3 25.7 40.6 35.8 27.6
27 Decrease1 Japan Takeda Pharmaceutical [P]
NASDAQTYO
59.6 (June 2007) 33.9 Decrease 40.2 45.6 47.8 37.5 34.3
28 Steady United States Alexion Pharmaceuticals[P]
NASDAQALXN
47.0 (Jul 2015) 30.9 Increase 26.7 27.4 43.1 36.7 26.0
29 Steady Japan Daiichi Sankyo [P]
NASDAQDSNKY
27.9 (June 2018) 30.7 Increase 27.5 35.3 38.8 33.2 28.7
30 Steady Japan Eisai Pharmaceutical [P]
TYO: 4523
24.7 (June 2018) 28.8 Increase 24.5 37.3 28.8 30.2 28.7
31 Steady United States Mylan [P]
NASDAQMYL
37.2 (Apr 2015) 18.9 Increase 27.5 30.3 38.8 33.2 35.7
32 Steady United States BioMarin [P]
NASDAQBMRN
24.0 (Jul 2015) 17.4 Increase 18.3 20.4 13.8 12.9 10.8
33 Steady United States Incyte [P]
NASDAQINCY
31.2 (Mar 2017) 14.6 Increase 18.3 15.4 10.6 7.3 4.6
34 Steady United States Perrigo [P]
NASDAQPRGO
29.0 (May 2017) 10.0 Decrease 9.9 9.5 8.3 14.7 12.2

Footnotes[edit]

  1. ^ The change is the companies' relative position in this list, compared to their relative position in the prior year; i.e, an increase would be moving closer to rank 1 and vice versa
  • B – Biotechnology company
  • P – Pharmaceutical company

See also[edit]

References[edit]

  1. ^ "Healthcare – Google Finance".
  2. ^ "Healthcare – Google Finance".
  3. ^ "The World's Biggest Public Companies". Forbes.
  4. ^ "• Top biotech and pharmaceutical companies market value 2015 - Statistic". Statista.